Healthcare -
Biotechnology - NASDAQ - US
$ 0.7113
6.24 %
$ 42.1 M
Market Cap
-0.89
P/E
Price Target
Average
1165.29%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
19.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Elevation Oncology, Inc.
Wall Street analysts predict an average 1-year price target for ELEV of $9 , with forecasts ranging from
a
low of
$8 to a high of $10 .
ELEV Lowest Price Target
Wall Street Target
8 USD
1024.70%
ELEV Average Price Target
Wall Street Target
9 USD
1165.29%
ELEV Highest Price Target
Wall Street Target
10 USD
1305.88%
REVENUE FORECAST
Revenue Forecast Chart ELEV
EBIT FORECAST
EBIT Forecast Chart ELEV
NET INCOME FORECAST
Net Income Chart ELEV